AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Trends Analyst Outlook Journalist POV

65 hedge funds and large institutions have $88.5M invested in Avadel Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

55% less call options, than puts

Call options by funds: $160K | Put options by funds: $354K

67% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 15

Holders
65
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$160K
Puts
$354K
Net Calls
Net Calls Change

Top Buyers

1
+$5.99M
2
+$1.3M
3
+$299K
4
BCM
Brown Capital Management
Maryland
+$225K
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$129K

Top Sellers

1
-$2.06M
2
-$2.03M
3
-$1.66M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$924K
5
GCP
GSA Capital Partners
United Kingdom
-$830K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$17K
52
$15K
53
$13K
54
$12K
55
$11K
56
$10K
57
$4K
58
$2K
59
$1K
60
$1K
61
$1K
62
$1K
63
$1K
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4